Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1955 2
1959 1
1960 4
1961 8
1962 11
1963 14
1964 14
1965 6
1966 13
1967 18
1968 10
1969 9
1970 14
1971 15
1972 11
1973 9
1974 12
1975 13
1976 9
1977 21
1978 21
1979 18
1980 22
1981 18
1982 33
1983 28
1984 40
1985 29
1986 35
1987 24
1988 46
1989 43
1990 43
1991 41
1992 48
1993 41
1994 51
1995 46
1996 60
1997 66
1998 85
1999 97
2000 78
2001 72
2002 88
2003 82
2004 93
2005 121
2006 122
2007 111
2008 99
2009 139
2010 127
2011 137
2012 172
2013 173
2014 194
2015 213
2016 228
2017 204
2018 185
2019 182
2020 244
2021 224
2022 182
2023 185
2024 106

Text availability

Article attribute

Article type

Publication date

Search Results

4,498 results

Results by year

Filters applied: . Clear all
Page 1
iPLAT1: the first-in-human clinical trial of iPSC-derived platelets as a phase 1 autologous transfusion study.
Sugimoto N, Kanda J, Nakamura S, Kitano T, Hishizawa M, Kondo T, Shimizu S, Shigemasa A, Hirai H, Arai Y, Minami M, Tada H, Momose D, Koh KR, Nogawa M, Watanabe N, Okamoto S, Handa M, Sawaguchi A, Matsuyama N, Tanaka M, Hayashi T, Fuchizaki A, Tani Y, Takaori-Kondo A, Eto K. Sugimoto N, et al. Among authors: shimizu s. Blood. 2022 Dec 1;140(22):2398-2402. doi: 10.1182/blood.2022017296. Blood. 2022. PMID: 36112961 Free article. Clinical Trial. No abstract available.
Engineering CD3/CD137 dual specificity into a DLL3-targeted T-cell engager enhances T-cell infiltration and efficacy against small cell lung cancer.
Mikami H, Feng S, Matsuda Y, Ishii S, Naoi S, Azuma Y, Nagano H, Asanuma K, Kayukawa Y, Tsunenari T, Kamikawaji S, Iwabuchi R, Shinozuka J, Yamazaki M, Kuroi H, Ho SSW, Gan SW, Chichili P, Pang CL, Yeo CY, Shimizu S, Hironiwa N, Kinoshita Y, Shimizu Y, Sakamoto A, Muraoka M, Takahashi N, Kawa T, Shiraiwa H, Mimoto F, Kashima K, Kamata-Sakurai M, Ishikawa S, Aburatani H, Kitazawa T, Igawa T. Mikami H, et al. Among authors: shimizu s. Cancer Immunol Res. 2024 Mar 20. doi: 10.1158/2326-6066.CIR-23-0638. Online ahead of print. Cancer Immunol Res. 2024. PMID: 38558120
Molecular mechanisms and biological roles of GOMED.
Noguchi S, Shimizu S. Noguchi S, et al. Among authors: shimizu s. FEBS J. 2022 Nov;289(22):7213-7220. doi: 10.1111/febs.16281. Epub 2021 Nov 29. FEBS J. 2022. PMID: 34787961 Free article. Review.
Intestinal Atp8b1 dysfunction causes hepatic choline deficiency and steatohepatitis.
Tamura R, Sabu Y, Mizuno T, Mizuno S, Nakano S, Suzuki M, Abukawa D, Kaji S, Azuma Y, Inui A, Okamoto T, Shimizu S, Fukuda A, Sakamoto S, Kasahara M, Takahashi S, Kusuhara H, Zen Y, Ando T, Hayashi H. Tamura R, et al. Among authors: shimizu s. Nat Commun. 2023 Nov 21;14(1):6763. doi: 10.1038/s41467-023-42424-x. Nat Commun. 2023. PMID: 37990006 Free PMC article.
Biogenesis of fibrils requires C-mannosylation of PMEL.
Kawahara R, Usami T, Arakawa S, Kamo H, Suzuki T, Komatsu R, Hara H, Niwa Y, Shimizu E, Dohmae N, Shimizu S, Simizu S. Kawahara R, et al. Among authors: shimizu s. FEBS J. 2023 Nov;290(22):5373-5394. doi: 10.1111/febs.16927. Epub 2023 Aug 18. FEBS J. 2023. PMID: 37552474
Cooperativity in Sorption Isotherms.
Shimizu S, Matubayasi N. Shimizu S, et al. Langmuir. 2023 Oct 3;39(39):13820-13829. doi: 10.1021/acs.langmuir.3c01243. Epub 2023 Sep 22. Langmuir. 2023. PMID: 37738037 Free PMC article.
The First Synthesis of Subporphyrins.
Shimizu S. Shimizu S. Angew Chem Int Ed Engl. 2023 Mar 1;62(10):e202217099. doi: 10.1002/anie.202217099. Epub 2023 Jan 12. Angew Chem Int Ed Engl. 2023. PMID: 36539354 Review.
Aberrant MUC Immunohistochemical Expressions in Inflammatory Bowel Diseases.
Hamamoto Y, Kawamura M, Uchida H, Takagahara K, Katori C, Asai H, Harada H, Shimizu S, Morii E, Yoshida K. Hamamoto Y, et al. Among authors: shimizu s. Appl Immunohistochem Mol Morphol. 2023 Feb 1;31(2):107-112. doi: 10.1097/PAI.0000000000001096. Epub 2022 Dec 28. Appl Immunohistochem Mol Morphol. 2023. PMID: 36728756 Review.
4,498 results